F-star Therapeutics CEO Eliot Forster's 2021 pay falls 38% to $2.8M
F-star Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
F-star Therapeutics reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, four executives at F-star Therapeutics received on average a compensation package of $1.4M, a 2% decrease compared to previous year.
Average pay of disclosed executives at F-star Therapeutics
Eliot Forster, Chief Executive Officer, received $2.8M in total, which decreased by 38% compared to 2020. 43% of Forster's compensation, or $1.2M, was in stock awards. Forster also received $197K in bonus, $719K in option awards, $665K in salary, as well as $4K in other compensation.
Darlene Deptula-Hicks, Chief Financial Officer, received a compensation package of $1.1M, which increased by 16% compared to previous year. 56% of the compensation package, or $636K, was in salary.
Louis Kayitalire, Chief Medical Officer, earned $934K in 2021, a 9% decrease compared to previous year.
Neil Brewis, PhD., DSc, Chief Scientific Officer, received $838K in 2021, which decreases by 50% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 22, 2022.